Lourdes Cardiology Services
Voorhees Township, New Jersey 08043-4322
0 studies enrolling now · 23 studies all time
What they study most
Acute Coronary Syndrome, Acute Kidney Injury (AKI), Acute Myocardial Infarction (AMI), Arrhythmia, Atrial Fibrillation, CIED Related Infection, Cardiovascular Disease, Congestive Heart Failure, Coronary Artery Disease, Coronary Occlusion, Heart Diseases, Heart Failure
Studies at this site
- Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure — Completed
- SyncAV Post-Market Trial — Running, not enrolling
- Hemodynamic-GUIDEd Management of Heart Failure — Completed
- Optisure Lead Post Approval Study — Stopped early
- Heart Failure Optimization Study — Completed
- Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery — Completed
- Extravascular ICD Pivotal Study — Completed
- REmodeling the Left Ventricle With Atrial Modulated Pacing — Completed
- AdaptResponse Clinical Trial — Completed
- SHIELD II Clinical Investigation — Stopped early
- SelectSecure 3830 Lead Imaging — Completed
- INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure — Completed
- Attain Stability™ Quad Clinical Study — Completed
- Reveal LINQ™ Heart Failure — Completed
- World-wide Randomized Antibiotic Envelope Infection Prevention Trial — Completed
- QuickFlex Micro Left Ventricular Lead Post Approval Study — Completed
- The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
- Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients — Completed
- Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) — Completed
- The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
- REVEAL AF: Incidence of AF in High Risk Patients — Completed
- AngelMed for Early Recognition and Treatment of STEMI — Completed
- Medtronic Reveal LINQ™ In-Office 2 (RIO 2) Study United States — Completed